Premier Biomedical, Inc. (OTCMKTS:BIEI) Sees Large Growth in Short Interest

Premier Biomedical, Inc. (OTCMKTS:BIEI) was the recipient of a large increase in short interest in May. As of May 15th, there was short interest totaling 598,286 shares, an increase of 3,933.5% from the April 30th total of 14,833 shares. Based on an average daily trading volume, of 92,722,395 shares, the days-to-cover ratio is currently 0.0 days.

Premier Biomedical Price Performance

Premier Biomedical stock traded down $0.00 during mid-day trading on Wednesday, hitting $0.00. 41,616,903 shares of the company were exchanged, compared to its average volume of 19,551,488. Premier Biomedical has a 12-month low of $0.00 and a 12-month high of $0.00.

About Premier Biomedical

Premier Biomedical, Inc, a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule, and pet product; sequential-dialysis technique for cancer, Alzheimer's disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries.